2nd December 2024 –Uni-Bio Science Group Limited is pleased to announce two significant milestones that demonstrate the Group’s continued growth and innovation in the field of medical aesthetics and dermatological solutions.
2024-12-02
View details
Achieved Record High Revenue of HK$273.6M and Net Profit of HK$67.4M Further Penetration to Osteoporosis, Ophthalmology, and Medical Aesthetic Device Markets
2024-08-28
View details
Recently, Uni-Bio Science Group Limited is pleased to announce a strategic cooperation with Chongqing Minji Medical Device Co., Ltd.
2024-07-10
View details
Record-breaking Revenue of HK$484.7M and Net Profit of HK$70.9M，Pioneering Breakthroughs in Osteoporosis, Medical Aesthetics, and Ophthalmology Markets
2024-03-28
View details
Uni-Bio Science Group Limited is pleased to announce the acceptance of its marketing application for Diquafosol Sodium eye drops by the China National Medical Products Administration (“NMPA”) on 23 January 2024, with the acceptance number “CYHS2400318“.
2024-01-23
View details
京公网安备 11011402013046号京ICP备17029593号-2
